Top upgrades and downgrades on 4/27

Analysts Notebook wrote a column · Apr 27, 2022 06:29

Upgrades

• $Ares Capital Corp(ARCC.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $22

• $Avery Dennison(AVY.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $195

• $Avery Dennison(AVY.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $195 (from $215)

• $Brookfield Asset Management(BAM.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $71.50 (from $68)

• $Ecolab(ECL.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $190 (from $191)

• $Estee Lauder(EL.US)$ : Edward Jones Upgrades to Buy from Hold

• $Franklin Electric(FELE.US)$ : Seaport Global Securities Upgrades to Buy from Neutral - PT $80

• $Halliburton(HAL.US)$ : HSBC Upgrades to Buy from Hold - PT $41.60 (from $36.60)

• $Robert Half(RHI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $133 (from $123)

• $Rush Street Interactive(RSI.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $10 (from $11)

• $Schlumberger(SLB.US)$ : HSBC Upgrades to Buy from Hold - PT $44.20 (from $40.60)

Downgrades

• $Bank of New York Mellon(BK.US)$ : JPMorgan Downgrades to Neutral from Overweight - PT $51.50 (from $59)

• $Capital One Financial(COF.US)$ : Piper Sandler Downgrades to Neutral from Overweight - PT $143 (from $164)

• $Carter's(CRI.US)$ : BofA Securities Downgrades to Underperform from Buy - PT $82 (from $120)

• $Euronav(EURN.US)$ : Jefferies Downgrades to Hold from Buy - PT $12 (from $13)

• $JetBlue Airways(JBLU.US)$ : JPMorgan Double Downgrades to Underweight from Overweight - PT $12 (from $24)

• $Molecular(MOLN.US)$ : Credit Suisse Downgrades to Underperform from Neutral

• $Orange SA(ORAN.US)$ : CFRA Downgrades to Buy from Strong Buy - PT $14

• $PotlatchDeltic Corp(PCH.US)$ : RBC Capital Downgrades to Sector Perform from Outperform - PT $60 (from $65)

• $SkyWest(SKYW.US)$ : Raymond James Downgrades to Market Perform from Outperform

Initiated

• $Appian(APPN.US)$ : Goldman Sachs initiates at Buy - PT $70

• $Cazoo(CZOO.US)$ : UBS initiates at Neutral - PT $2.60

• $Insmed(INSM.US)$ : Goldman Sachs initiates at Buy - PT $56

• $Jacobs Engineering(J.US)$ : RBC Capital initiates at Outperform - PT $173

• $Organon & Co(OGN.US)$ : Goldman Sachs initiates at Buy - PT $40

• $Royalty Pharma(RPRX.US)$ : Goldman Sachs initiates at Buy - PT $56

• $Sera Prognostics(SERA.US)$ : Berenberg initiates at Buy - PT $13

• $Sea(SE.US)$ : CICC initiates at Outperform - PT $141

• $UroGen Pharma Ltd(URGN.US)$ : Berenberg initiates at Buy - PT $20

• $Vor Biopharma(VOR.US)$ : Goldman Sachs initiates at Neutral - PT $6

• $Warner Bros Discovery(WBD.US)$ : Barclays initiates at Equalweight - PT $24

• $WalkMe(WKME.US)$ : Goldman Sachs initiates at Buy - PT $23

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

241K Views

Comment

Moomoo News Official Account

How do analysts evaluate the market?

15KFollowers

8Following

35KVisitors